Pharmafile Logo
Pharmafocus logo
Advanced Search

API

Showing 15 posts of 59 posts found.

Novasep invest €30m in ‘world’s largest chromatography plant’

October 11, 2012
Manufacturing and Production API, Novasep

French purification specialist Novasep has said it plans to invest €30 million in a new plant at its site in …

News

Boehringer closing Petersburg API plant

September 25, 2012
Manufacturing and Production API, Boehringer, Petersburg, chemicals

Boehringer Ingelheim has decided to close down one of its active pharmaceutical ingredient (API) manufacturing facilities in the US because …

News

CMO market on the up says new study

September 24, 2012
Manufacturing and Production API, CMO, manufacturing

The global contract manufacturing market is expected to reach a value of nearly $48 billion this year on the back …

News

Opposition mounting to EU’s API import regulations

August 7, 2012
Manufacturing and Production API, EU, TBT, WTO, manufacturing

Changes to the EU’s rules governing the importation of active pharmaceutical ingredients (APIs) are being opposed by the governments of …

News
Siegfried image

Siegfried to build new API plant in China

July 10, 2012
Manufacturing and Production AMP, API, Hanko, Siegfried

Swiss contract manufacturing organisation Siegfried has announced plans to build a new manufacturing facility in Nantong, near Shanghai in China. …

News
Merck image

Merck closes Cherokee Pharma plant

July 3, 2012
Manufacturing and Production API, Cherokee Pharmaceuticals, Merck, manufacturing

Merck & Co has decided to close down part of a US plant operated by subsidiary Cherokee Pharmaceuticals after failing …

News

Albemarle expands API capacity at Michigan facility

June 28, 2012
Manufacturing and Production API, Albemarle, Michigan, manufacturing

Fine chemicals, polymers and catalysts specialist Albemarle has brought new manufacturing capacity for active pharmaceutical ingredients (APIs) online at its …

News
Akzo Nobel image

Akzo Nobel’s Mexican API plant all clear

June 19, 2012
Manufacturing and Production API, Akzo Nobel, FDA, manufacturing

Akzo Nobel has brought a manufacturing facility for active pharmaceutical ingredients in Mexico that failed an inspection last year back …

News

Mitsubishi Tanabe exits API business

May 22, 2012
Manufacturing and Production API, Mitsubishi, Phil Taylor, Tanabe

Mitsubishi Tanabe Pharma has said it will withdraw from the fine chemical business, including active pharmaceutical ingredient (API) supply, and …

News

WHO joins regulators in manufacturing inspections alliance

March 12, 2012
Manufacturing and Production API, EMA, FDA, WHO, manufacturing

The World Health Organization will join a shared inspection programme for active pharmaceutical ingredient (API) facilities piloted last year by …

News

Shared API inspections project declared a success

August 9, 2011
Manufacturing and Production API, EMA, FDA, TGA, pharma manufacturing news, regulatory inspections

A two-year facility inspection programme carried out by regulators in the USA, Europe and Australia has been deemed a success …

News

Functional excipients driving US market growth

June 2, 2011
Manufacturing and Production API, excipients, functional excipients

Drugmakers are increasingly using more sophisticated excipients and blends in order to defend against generic competition, according to new market …

News

GSK pilots wireless sensors to improve plant efficiency

April 11, 2011
Manufacturing and Production API, GSK, Ireland

GlaxoSmithKline has started pilot testing of a wireless system of flow and pressure transmitters to try to improve the efficiency …

News

Aurobindo sells Chinese API unit to Sinopharm

January 13, 2011
Manufacturing and Production API, Aurobindo Pharma, China, Sinopharm Weiqida Pharmaceutical, active pharmaceutical ingredient

Indian company Aurobindo Pharma intends to sell off a loss-making active pharmaceutical ingredient unit to Sinopharm, the largest pharmaceutical company …

News

Cambrex buys Zenara to enter nicotine replacement market

November 9, 2010
API, Cambrex, Cambrex Zenara, India, Pharmaceutical ingredients, Zenara Pharma, generic APIs, nicotine replacement

Pharmaceutical ingredient manufacturer Cambrex has taken a majority stake in Indian formulator Zenara Pharma for $20 million in a move …

News
The Gateway to Local Adoption Series

Latest content

From vaccine innovation pathways to growth powerhouse: how the UK is transforming clinical trials

October 2, 2025

Five Facts about Breast Cancer

October 2, 2025

Unlocking nature’s pharmacy: how tea leaves and marine organisms could help transform breast cancer treatment

October 2, 2025

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

September 26, 2025

CSL Behring’s angioedema treatments receives NICE recommendation

September 26, 2025